Danny Hart

2012

In 2012, Danny Hart earned a total compensation of $501.5K as Vice President, Business Development at PDL BioPharma, a 73% increase compared to previous year.

Compensation breakdown

Bonus$58,600
Non-Equity Incentive Plan$135,658
Salary$237,000
Stock Awards$30,200
Other$40,000
Total$501,458

Hart received $237K in salary, accounting for 47% of the total pay in 2012.

Hart also received $58.6K in bonus, $135.7K in non-equity incentive plan, $30.2K in stock awards and $40K in other compensation.

Rankings

In 2012, Danny Hart's compensation ranked 8,749th out of 11,487 executives tracked by ExecPay. In other words, Hart earned more than 23.8% of executives.

ClassificationRankingPercentile
All
8,749
out of 11,487
24th
Division
Manufacturing
3,186
out of 4,253
25th
Major group
Chemicals And Allied Products
857
out of 1,198
29th
Industry group
Drugs
628
out of 920
32nd
Industry
Biological Products, Except Diagnostic Substances
107
out of 160
33rd
Source: SEC filing on April 16, 2015.

Hart's colleagues

We found four more compensation records of executives who worked with Danny Hart at PDL BioPharma in 2012.

2012

John McLaughlin

PDL BioPharma

Chief Executive Officer

2012

Christopher Stone

PDL BioPharma

General Counsel

2012

Caroline Krumel

PDL BioPharma

Former Vice President of Finance and Principal Accounting Officer

2012

Bruce Tomlinson

PDL BioPharma

Chief Financial Officer

You may also like